(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia control, as well as optical products and services...
Stats | |
---|---|
आज की मात्रा | 450 500 |
औसत मात्रा | 1.25M |
बाजार मूल्य | 2.60B |
EPS | HKD0 ( 2024-03-28 ) |
अगली कमाई की तारीख | ( HKD0 ) 2024-06-06 |
Last Dividend | HKD0.174 ( 2023-06-12 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 10.39 |
ATR14 | HKD0.00700 (0.19%) |
मात्रा सहसंबंध
Chaoju Eye Care Holdings सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Chaoju Eye Care Holdings सहसंबंध - मुद्रा/वस्त्र
Chaoju Eye Care Holdings वित्तीय
Annual | 2023 |
राजस्व: | HKD1.37B |
सकल लाभ: | HKD621.13M (45.35 %) |
EPS: | HKD0.330 |
FY | 2023 |
राजस्व: | HKD1.37B |
सकल लाभ: | HKD621.13M (45.35 %) |
EPS: | HKD0.330 |
FY | 2022 |
राजस्व: | HKD990.04M |
सकल लाभ: | HKD434.70M (43.91 %) |
EPS: | HKD0.270 |
FY | 2021 |
राजस्व: | HKD997.79M |
सकल लाभ: | HKD448.67M (44.97 %) |
EPS: | HKD0.235 |
Financial Reports:
No articles found.
Chaoju Eye Care Holdings Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.174 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.104 | 2022-06-10 |
Last Dividend | HKD0.174 | 2023-06-12 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 2 | -- |
Total Paid Out | HKD0.278 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.03 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.93 | |
Div. Directional Score | 8.35 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
3933.HK | Ex Dividend Junior | 2023-09-14 | Sporadic | 0 | 0.00% | |
1776.HK | Ex Dividend Junior | 2023-07-11 | Annually | 0 | 0.00% | |
0817.HK | Ex Dividend Junior | 2023-09-18 | Semi-Annually | 0 | 0.00% | |
2359.HK | Ex Dividend Knight | 2023-06-05 | Annually | 0 | 0.00% | |
1345.HK | Ex Dividend Junior | 2023-10-04 | Semi-Annually | 0 | 0.00% | |
0390.HK | Ex Dividend Junior | 2023-07-19 | Annually | 0 | 0.00% | |
6601.HK | Ex Dividend Knight | 2023-09-13 | Annually | 0 | 0.00% | |
1897.HK | Ex Dividend Knight | 2023-07-05 | Semi-Annually | 0 | 0.00% | |
0921.HK | Ex Dividend Junior | 2023-07-10 | Sporadic | 0 | 0.00% | |
0052.HK | Ex Dividend Knight | 2023-09-12 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.167 | 1.500 | 6.66 | 9.99 | [0 - 0.5] |
returnOnAssetsTTM | 0.0783 | 1.200 | 7.39 | 8.87 | [0 - 0.3] |
returnOnEquityTTM | 0.0982 | 1.500 | -0.0200 | -0.0300 | [0.1 - 1] |
payoutRatioTTM | 0.479 | -1.000 | 5.21 | -5.21 | [0 - 1] |
currentRatioTTM | 5.05 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.34 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.352 | 1.500 | 3.60 | 5.40 | [0.2 - 2] |
debtRatioTTM | 0.0544 | -1.500 | 9.09 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 44.90 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.540 | 2.00 | 9.82 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.540 | 2.00 | 9.73 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0674 | -1.500 | 9.73 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.454 | 1.000 | 5.77 | 5.77 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.211 | 1.000 | 7.77 | 7.77 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.34 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.469 | 0.800 | -0.210 | -0.168 | [0.5 - 2] |
Total Score | 11.78 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 10.44 | 1.000 | 9.05 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0982 | 2.50 | -0.0128 | -0.0300 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.540 | 2.00 | 9.82 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 5.02 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.540 | 2.00 | 9.82 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.479 | 1.500 | 5.21 | -5.21 | [0 - 1] |
pegRatioTTM | 0.177 | 1.500 | -2.15 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.272 | 1.000 | 5.70 | 0 | [0.1 - 0.5] |
Total Score | 4.93 |
Chaoju Eye Care Holdings
Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia control, as well as optical products and services. The company also provides basic ophthalmic services, including cataract, glaucoma, ocular fundus diseases, ocular muscle diseases, refraction errors, pediatric ophthalmology, ocular surface diseases, lacrimal diseases, orbital diseases, oculoplastic, and ocular trauma. As of December 31, 2021, it operated a network of 17 ophthalmic hospitals, 24 optical centers, and 2 clinics in Zhejiang, Jiangsu, Shanxi, and Hebei provinces, as well as in Inner Mongolia. The company was founded in 1988 and is headquartered in Beijing, China.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं